SALIGARD 60- sodium salicylate solution 
Aurora Pharmaceutical, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

SaliGard™
Sodium Salicylate
Concentrate 60% w/v

ACTIVE INGREDIENTS
Sodium Salicylate60% w/v
OTHER INGREDIENTS
Water, sodium phosphate dibasic, hydrochloric acid 

INDICATIONS

For use in the drinking water of poultry and swine as an aid in reducing pain, fever and inflammation.

DIRECTIONS FOR USE

For Analgesic and Antipyretic Use

Water Proportioner Use:

Add 6.5 ounces (192 mL) of Sodium Salicylate 60% Concentrate to make 1 gallon of stock solution and administer through a medicator metered at 1:128 (1 ounce per gallon). This will achieve a target dose of 11.3 mg/lb (25 mg/kg) body weight daily.

Livestock Tank Use:

Add 6.5 ounces (192 mL) of Sodium Salicylate 60% Concentrate to 128 gallons of drinking water. This will achieve a target dose of 11.3 mg/lb (25 mg/kg) body weight daily.

For Anti-Inflammatory/Anti-Prostaglandin Use — Day 1

Water Proportioner Use:

Add 14 ounces (414 mL) of Sodium Salicylate 60% Concentrate to make 1 gallon of stock solution and administer through a medicator metered at 1:128 (1 ounce per gallon). This will achieve a target dose of 22.7 mg/lb (50 mg/kg) body weight daily.

Livestock Tank Use:

Add 14 ounces (414 mL) of Sodium Salicylate 60% Concentrate to 128 gallons of drinking water. This will achieve a target dose of 22.7 mg/lb (50 mg/kg) body weight daily.

Day 2 through 7

Water Proportioner Use:

Add 8 ounces (236 mL) of Sodium Salicylate 60% Concentrate to make 1 gallon of stock solution and administer through a medicator metered at 1:128 (1 ounce per gallon). This will achieve a target dose of 13.6 mg/lb (30 mg/kg) body weight daily.

Livestock Tank Use:

Add 8 ounces (236 mL) of Sodium Salicylate 60% Concentrate to 128 gallons of drinking water. This will achieve a target dose of 13.6 mg/lb (30 mg/kg) body weight daily.

Prepare fresh solutions daily. Repeat as necessary.

WARNING

Do not administer concentrated solution by direct oral administration — gastro-intestinal irritation or overdose may occur. 

Do not use in piglets less than 3 weeks of age.

Do not use if allergic or sensitive to the active ingredients.

STORAGE

Store at 20°–25° C (68°–77° F). Excursions permitted between 15°–30° C (59°–86° F).

CAUTION

Keep container closed when not in use. Product may solidify at cold storage temperatures. Place container in room temperature storage, which will thaw the solution. If precipitate remains after thawing, place in warm water. Gently invert container to ensure dissolution and uniformity of product. Gradual darkening will not affect product stability.

Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.

Take time image

MANUFACTURED IN THE USA

REORDER NO: 21002

MANUFACTURED BY:
Aurora Pharmaceutical, Inc.
NORTHFIELD, MINNESOTA 55057
1-888-215-1256
www.aurorapharmaceutical.com

IN 50-1714 09/2021

PRINCIPAL DISPLAY PANEL - 3.79 Liter Bottle Label

NDC 51072-117-00

SaliGardTM

Sodium Salicylate
Concentrate 60% w/v

For Use in Livestock Only

Keep Out of Reach of Children

Net Contents:
1 Gallon (3.79 Liters)

AURORA PHARMACEUTICAL®

Principal Display Panel-3.79 Liters Bottle Label

SALIGARD 60 
sodium salicylate solution
Product Information
Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:51072-117
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM SALICYLATE (UNII: WIQ1H85SYP) (SALICYLIC ACID - UNII:O414PZ4LPZ) SODIUM SALICYLATE60 g  in 100 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51072-117-003790 mL in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/04/2022
Labeler - Aurora Pharmaceutical, Inc. (832848639)
Establishment
NameAddressID/FEIBusiness Operations
Aurora Pharmaceutical, Inc.832848639manufacture

Revised: 5/2022
Document Id: af9a1add-2dc5-49b5-8800-d6d7ebf6f09f
Set id: 2c56c711-a8b5-4db0-9b09-ae74b8c7c32d
Version: 1
Effective Time: 20220504
 
Aurora Pharmaceutical, Inc.